News for Bellicum Pharmaceuticals, Inc. (BLCM)

Bellicum Pharmaceuticals, Inc. 3730 Kirby Drive, Ste. 1200 Houston, TX 77098 Dear Stockholders of Bellicum Pharmaceuticals, Inc.: ...

— Alan A. Musso appointed as CFO effective August 7, 2023 —CAMBRIDGE, Mass., Aug. 03, 2023 -- Fulcrum Therapeutics, Inc.® , a clinical-stage biopharmaceutical company focused on improving the...

NEW YORK, July 06, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the ordinary shares of Puhui Wealth Investment...

/PRNewswire/ -- The "CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Target Antigen, By Indication, By Region, Segment Forecast,...

/PRNewswire/ -- A latest research report [115+] pages with 360-Degree visibility, titled "CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis...

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.17%

U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite turning higher later during the session on Monday. The Dow traded down 0.20% to 33,606.80 while the NASDAQ rose 0.14% to 12,252.53. The S&P 500, also rose, gaining, 0.04% to 4,138.09.

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.87%

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 400 points on Wednesday. The Dow traded down 1.32% to 31,732.39 while the NASDAQ fell 0.24% to 11,400.70. The S&P 500, also fell, dropping, 1.11% to 3,875.80.

HOUSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), today announced its decision to discontinue its ongoing Phase...

/PRNewswire/ --The "Global Engineered T Cells Market (2022-2027) by Type, Application, End User, Geography, Competitive Analysis and the Impact of Covid-19...

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.

Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share.

Read Investment Analysts’ Updated EPS Estimates for May 30th (AMPS, ARCO, ASHTY, ASML, ASTL, ATNM, AUGX, AXTI, BBAI, BBD) at ETF Daily News

Read Analysts’ New Coverage for May 29th (AACG, AAME, ABEO, ACOR, ACRX, ACU, AEMD, AEY, AEZS, AGFS) at ETF Daily News

Read Investment Analysts’ New Coverage for May 21st (AACG, AAME, ABEO, ACOR, ACRX, ACU, AEMD, AEY, AEZS, AGFS) at ETF Daily News

The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.55 A.M. ET)..

There is increased research and development for new drug discovery for the treatment of Esophageal Cancer. There are more than 80+ companies that are...

/PRNewswire/ -- The